Citation Impact
Citing Papers
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Oncogenic activation of the Notch1 gene by deletion of its promoter in Ikaros-deficient T-ALL
2010 StandoutNobel
4-Hydroxy-2-nonenal: a product and mediator of oxidative stress
2003 Standout
Activation of Stress Signaling Pathways by the End Product of Lipid Peroxidation
1999
CDK inhibitors: positive and negative regulators of G1-phase progression
1999 Standout
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Genetic analysis of β-thalassemia intermedia in Israel: Diversity of mechanisms and unpredictability of phenotype
1997
The p16INK4a/CDKN2A tumor suppressor and its relatives
1998
Respiratory Syncytial Virus Infection in Elderly and High-Risk Adults
2005 Standout
MYC on the Path to Cancer
2012 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
2002 Standout
The β-Thalassemias
1999 Standout
Chronic myeloid leukaemia as a model of disease evolution in human cancer
2007
Mismatch repair and nucleotide excision repair proteins cooperate in the recognition of DNA interstrand crosslinks
2009 StandoutNobel
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
2001 Standout
An Ion Channel Essential for Sensing Chemical Damage
2007 StandoutNobel
6 β-Thalassaemia
1993
Transient receptor potential channels: targeting pain at the source
2008 StandoutNobel
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells
1996 Standout
APC mutations occur early during colorectal tumorigenesis
1992 StandoutNature
Fetal cells in the maternal circulation: feasibility for prenatal diagnosis
1999
Loss of FBP function arrests cellular proliferation and extinguishes c-myc expression
2000
Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility
2002
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
2014
Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function
2004 StandoutNobel
NUP98 gene rearrangements and the clonal evolution of chronic myelogenous leukemia
2001
Post-transcriptional Control of Cyclooxygenase-2 Gene Expression
2000
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Role of reactive aldehyde in cardiovascular diseases
2000
Outcomes among 562 Recipients of Placental-Blood Transplants from Unrelated Donors
1998 Standout
8 The population genetics of the haemoglobinopathies
1993
Male breast cancer
2006 Standout
Non-B DNA structure-induced genetic instability
2006
Presence of fetal DNA in maternal plasma and serum
1997 Standout
Biology and management of relapsed acute myeloid leukaemia
2005
DNA triple helices: Biological consequences and therapeutic potential
2008
5 α-Thalassaemia
1993
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
Characterization of fusion partner genes in 114 patients with de novo acute myeloid leukemia and MLL rearrangement
2005
Sickle-cell disease
2010 Standout
Oncogenes and signal transduction
1991 Standout
Molecular characterization of a novel form of (A ) -thalassemia, deletion with a 3' breakpoint close to those of HPFH-3 and HPFH-4: insights for a common regulatory mechanism
1988
Molecular themes in oncogenesis
1991 StandoutNobel
TGFβ in Cancer
2008 Standout
Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program
2003
The cancer stem cell: premises, promises and challenges
2011 Standout
IκB Kinase, a Molecular Target for Inhibition by 4-Hydroxy-2-nonenal
2001
Selective growth response to IL‐3 of a human leukaemic cell line with megakaryoblastic features
1988
Disrupted dichotomous intracellular control of human papillomavirus infection in cancer of the cervix
1994 StandoutNobel
Molecular analysis of deletions in the human β-globin gene cluster: Deletion junctions and locations of breakpoints
1990 StandoutNobel
MicroRNA signatures in human cancers
2006 Standout
Homology requirements for unequal crossing over in humans.
1991 StandoutNobel
Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins
2004 Standout
Down's syndrome
2003 Standout
Analysis of cyclin-dependent kinase inhibitor genes (CDKN2A, CDKN2B, andCDKN2C) in childhood rhabdomyosarcoma
1996
7 Increased HbF in adult life
1993
World distribution of factor V Leiden
1995 Standout
ACG Clinical Guideline: Management of Benign Anorectal Disorders
2014
Why are some genetic diseases common?
1993
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
2005 StandoutNature
Notch and T cell malignancy
2004
Inhibition of touch cell fate by egl-44 and egl-46 in C. elegans
2001 StandoutNobel
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
2005 Standout
4-Hydroxynonenal and Cell Signalling
1998
Transforming growth factor β-induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation
2004
4-Hydroxynonenal As a Biological Signal: Molecular Basis and Pathophysiological Implications
1999
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
2003 Standout
Irritable Bowel Syndrome
2015 Standout
β-Arrestin2 mediates the initiation and progression of myeloid leukemia
2012 StandoutNobel
Molecular analysis of Japanese delta beta-thalassemia
1988
AUUUA Is Not Sufficient To Promote Poly(A) Shortening and Degradation of an mRNA: the Functional Sequence within AU-Rich Elements May Be UUAUUUA(U/A)(U/A)
1994
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.
1995 StandoutNobel
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Comparison of Quantitative Reverse Transcription-PCR to Viral Culture for Assessment of Respiratory Syncytial Virus Shedding
2003
Molecular analysis of a chromosomal translocation, t(9;14)(p13;q32), in a diffuse large-cell lymphoma cell line expressing the Ki-1 antigen.
1990 StandoutNobel
Memory Suppressor Genes: Inhibitory Constraints on the Storage of Long-Term Memory
1998 StandoutScienceNobel
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
2009 Standout
Sequence analysis of the gamma-globin gene locus from a patient with the deletion form of hereditary persistence of fetal hemoglobin
1990
Beta‐thalassaemia intermedia: is it possible consistently to predict phenotype from genotype?
1998
Backtracking leukemia to birth: Identification of clonotypic gene fusion sequences in neonatal blood spots
1997
Polycythemia vera: myths, mechanisms, and management
2002
Tyrosine Kinase Activity and Transformation Potency of bcr-abl Oncogene Products
1990 Science
Prognosis of inv(16)/t(16;16) acute myeloid leukemia (AML): a survey of 110 cases from the French AML Intergroup
2003
Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma Cells
1993 StandoutScienceNobel
Growth Factors and Cancer
1991 StandoutScience
Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum.
1996 Standout
Establishment of a peripheral T-cell lymphoma cell line showing amplification of the c-myc oncogene.
1988 StandoutNobel
Evolutionary Comparison of the Mechanism of DNA Cleavage with Respect to Immune Diversity and Genomic Instability
2012 StandoutNobel
Minimal residual disease levels assessed by NPM1 mutation–specific RQ-PCR provide important prognostic information in AML
2009
Prenatal diagnosis of fetal hemoglobin Lepore-Boston disease on maternal peripheral blood
1990
Isolation of fetal DNA from nucleated erythrocytes in maternal blood.
1990
The biology of CML blast crisis
2004
The breakpoint of a large deletion causing hereditary persistence of fetal hemoglobin occurs within an erythroid DNA domain remote from the beta-globin gene cluster
1989
Chronic Myelogenous Leukemia: Biology and Therapy
1999
Works of Anna Serra being referenced
Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients
2002
Multigenetic lesions in infant acute leukaemias: correlations with ALL‐1 gene status
1997
THE HOMOZYGOUS STATE FOR THE ‐87 C→Gβ+ THALASSAEMIA
1990
Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcripts
2002
Involvement of the cyclin‐dependent kinase‐4 inhibitor (CDKN2) gene in the pathogenesis of lymphoid blast crisis of chronic myelogenous leukaemia
1995
The C–T substitution in the distal CACCC box of the β‐globin gene promoter is a common cause of silent β thalassaemia in the Italian population
1990
Differential regulation of Notch signal transduction in leukaemia and lymphoma cells in culture
2002
Long-Term Study on the Effects of Visual Biofeedback and Muscle Training as a Therapeutic Modality in Pelvic Floor Dyssynergia and Slow-Transit Constipation
2004
Distribution of Ha-RAS-1 proto-oncogene alleles in breast cancer patients and in a control population
1988
4-Hydroxynonenal Specifically Inhibits c-myb but Does Not Affect c-fos Expressions in HL-60 Cells
1996
Molecular Defects Associated with the Acute Phase CML
1993
A newly‐characterized α‐thalassaemia‐1 deletion removes the entire α‐like globin gene cluster in an Italian family
1991
Circulating ‘trophoblast’ cells in pregnancy have maternal genetic markers
1988
Preferential clustering of chromosomal breakpoints in Burkitt's lymphomas and L3 type acute lymphoblastic leukemias with a t(8;14) translocation
1993
Delineation of specific beta-thalassemia mutations in high-risk areas of Italy: a prerequisite for prenatal diagnosis
1988
A benign form of thalassaemia intermedia may be determined by the interaction of triplicated α locus and heterozygous β-thalassaemia
1987
Two new translocations involving the 11q23 region map outside the MLL locus in myeloid leukemias.
2002
Mutations in the P53 and RAS family genes are associated with tumor progression of BCR/ABL negative chronic myeloproliferative disorders.
1993
The 3' ends of the deletions of Spanish delta beta zero-thalassemia and black HPFH 1 and 2 lie within 17 kilobases
1987
Italian type of deletional hereditary persistence of fetal hemoglobin
1986
Variability of the molecular defects corresponding to the presence of a Philadelphia chromosome in human hematologic malignancies
1988
A benign form of thalassaemia intermedia may be determined by the interaction of triplicated α locus and heterozygous β-thalassaemia
1987
Expression of cell cycle regulatory genes in chronic myelogenous leukemia.
1998
A 3' truncation of MYC caused by chromosomal translocation in a human T-cell leukemia increases mRNA stability.
1990
3' c-myc rearrangement in a human leukemic T-cell line.
1986
Molecular characterization of thalassemia intermedia in Italy.
1987